FIELD: biotechnology.
SUBSTANCE: invention is a combination of polynucleotides or proteins expressed from them, which are differentially expressed in animals exhibiting lean phenotype which is a result of one or several lean phenotype stimulating treatments comprising administering CLA, the consumption of a diet with high protein content and increase in physical exercises. At that the polynucleotides are selected from genes encoding proteins differentially expressed in liver and muscle tissues, which ID are listed in Table 6F, or from genes encoding proteins differentially expressed in adipose tissue, liver tissue and muscle tissue, which ID are listed in Table 6G, or from their fragments.
EFFECT: invention discloses gene expression profiles associated with improved or maintained lean body mass and with reduced content of body fat.
13 cl, 13 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATING, DIAGNOSING AND MONITORING OF RHEUMATOID ARTHRITIS | 2010 |
|
RU2539112C2 |
FODDER PRODUCT AND METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH ANIMAL OVERWEIGHT | 2009 |
|
RU2520853C2 |
TISSUE-SPECIFIC BIOMARKERS OF AGEING | 2010 |
|
RU2557313C2 |
APPLICATION OF ANTIOXIDANTS FOR GENE MODULATION | 2005 |
|
RU2433819C2 |
STEM/PROGENITOR CELL RECOVERY FROM AMNIOTIC MEMBRANE OF UMBILICAL CORD | 2005 |
|
RU2416638C2 |
METHODS OF TREATING INFLAMMATORY DISEASES OF COLON | 2009 |
|
RU2515156C2 |
POLYPEPTIDE AND IMMUNE MODULATION | 2014 |
|
RU2682651C2 |
PROBIOTIC BIFIDOBACTERIUM - Bifidobacterium Longum | 2009 |
|
RU2570557C2 |
CANCER TREATMENT WITH TG02 | 2017 |
|
RU2749025C2 |
METHOD OF OBTAINING POPULATION OF CELLS, EXPRESSING PURIPOTENCY MARKERS AND MARKERS, CHARACTERISTIC OF FORMED ENDODERM LINE | 2009 |
|
RU2553538C2 |
Authors
Dates
2014-11-10—Published
2009-08-10—Filed